Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Wu, Kenneth K.
Yen, B. Linju
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (MOST-104-2314-B-400-002, MOST-104-2321-B-400-021)
National Health Research Institutes (CS-105-PP-06)